PATENT CLAIM ANALYSIS

Application Number: 15985202
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "183000"]

Abstract:
The present invention relates to compositions and methods for the treatment of Parkinson's disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Parkinson's disease and related disorders targeting the alpha-synuclein aggregation network. In particular, the invention relates to compounds which, alone or in combination(s), can effectively protect neuronal cells from alpha-synuclein aggregates. The invention also relates to methods of producing a drug or a drug combination for treating Parkinson's disease and to methods of treating Parkinson's disease or a related disorder.

Claim (Index 10):
The method of  claim 11 , wherein said composition is administered repeatedly to the subject.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.96154
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14425926', '15142227', '14698920', '14473142', '15506308']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7959330957520042
- 35 USC 102 Novelty (BERT): 0.6173487725970963
- Combined Prediction Score: 0.7780746634365134
- Mean Citation Score: 412.849754
- Max Citation Score: 653.15393
- Similarity Product: 478.7914444177031

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test